Daoud Dajani, MD
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Johnson & Johnson accounts for 85.6% of it on its own, with 38 other manufacturers making up the rest. Among urology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 208 payments — averaging $224.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$40K
- Intuitive Surgical$2K
- Teleflex LLC$699
- Sumitomo Pharma America, Inc.$336
- Progenics Pharmaceuticals, Inc.$335
- Myriad Genetic Laboratories, Inc.$315
- plus $3K from 33 others
What the payments were for
- Consulting fees$8,67319%
- Speaking & faculty fees$27,42159%
- Travel & lodging$3,7178%
- Food & beverage$6,90115%
- Gifts$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(4 entities) | 71 | $39,987 |
| Intuitive Surgical | 6 | $2,060 |
| Teleflex LLC | 11 | $699 |
| Sumitomo Pharma America, Inc. | 12 | $336 |
| Progenics Pharmaceuticals, Inc. | 8 | $335 |
| Myriad Genetic Laboratories, Inc. | 7 | $315 |
| Dendreon Pharmaceuticals LLC | 6 | $290 |
| Cook Incorporated | 1 | $250 |
| Medtronic | 4 | $236 |
| Immunitybio, Inc. | 4 | $222 |
| Urogen Pharma, Inc. | 8 | $202 |
| Bayer | 7 | $186 |
| Pfizer | 7 | $178 |
| Boston Scientific | 6 | $160 |
| AbbVie | 6 | $160 |
| Conmed Corporation | 2 | $135 |
| Coloplast | 4 | $98 |
| Caldera Medical, Inc | 1 | $79 |
| Merck | 4 | $74 |
| Astellas Pharma US Inc | 3 | $69 |
| Olympus America Inc. | 3 | $68 |
| Tempus AI, Inc | 3 | $65 |
| Endo USA, Inc. | 2 | $42 |
| Ferring Pharmaceuticals Inc. | 2 | $42 |
| Telix Pharmaceuticals | 2 | $42 |
| Axonics, Inc. | 2 | $42 |
| Endo Pharmaceuticals Inc. | 2 | $39 |
| Cook Medical LLC | 2 | $38 |
| Antares Pharma, Inc. | 1 | $34 |
| ABC Home Medical Supply, Inc. | 2 | $32 |
| Novartis | 1 | $31 |
| Blue Earth Diagnostics | 1 | $27 |
| AstraZeneca | 1 | $26 |
| Bioprotect Medical, Inc. | 1 | $26 |
| Lantheus Medical Imaging, Inc. | 1 | $25 |
| Boehringer Ingelheim | 1 | $23 |
| Photocure Inc | 1 | $21 |
| Caris MPI, Inc. | 1 | $20 |
| Accord Healthcare, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$46,735 in reported general payments places this provider in the 90th percentile of 274 urology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 37 | $586,230 |
| MyrbetriqMirabegron | 37 | $27,028 |
| PremarinEstrogens, Conjugated | 24 | $10,525 |
| Estradiol | 44 | $3,270 |
| Tamsulosin Hcl | 98 | $1,080 |
| Oxybutynin Chloride ErOxybutynin Chloride | 36 | $513 |
| NitrofurantoinNitrofurantoin Macrocrystal | 14 | $218 |
| Finasteride | 12 | $208 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $76 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $41 |
| Ciprofloxacin Hcl | 26 | $30 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $39,987 | $586,23037 claims |
| Astellas Pharma US IncMyrbetriq | $69 | $27,02837 claims |
| PfizerPremarin | $178 | $10,52524 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 274 urology providers in Maryland.
Other urology in Largo
- Matthew AllawayCumberland$20.6M
- Benjamin LowentrittBaltimore$549K
- Julio DavalosGlen Burnie$490K
- Sankar KausikBel Air$375K
- Laura GiustoOwings Mills$367K
- Amin HeratiBaltimore$160K
- Rian DicksteinHanover$144K
- Max KatesBaltimore$139K
- Arthur BurnettBaltimore$132K
- Aaron WeinbergBaltimore$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.